TYNDALL JOSEPH A.
Director
- Shares
- 3,500
- Price
- $49.70
- Value
- $173,940
AXGN
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$4,657,286
0 buyers · 4 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$15,189,047
11 distinct insiders
Highlighted alerts
25
17 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
AXGN overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
This reflects the number of restricted stock units ("RSUs") that vested on March 16, 2026. This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting dates. All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date.
Reason: tax_withholding. The filing footnotes identify tax withholding.
Voluntary purchases and sales; administrative noise stays hidden.
TYNDALL JOSEPH A.
Director
Wendell Amy McBride
Director
Began Marc A
EVP & General Counsel
Weiler Kathy Johnson
Director
Wendell Amy McBride
Director
JOHNSON JOHN
Director
Weiler Kathy Johnson
Director
Kemp Jens
Chief Marketing Officer
Hartley Lindsey Marie
CFO
Hartley Lindsey Marie
CFO
Quackenbush Doris
Sales VP
Wendell Amy McBride
Director
Wendell Amy McBride
Director
Wendell Amy McBride
Director
Weiler Kathy Johnson
Director
Weiler Kathy Johnson
Director
Weiler Kathy Johnson
Director
Hartley Lindsey Marie
CFO
Began Marc A
EVP & General Counsel
DALE MICHAEL D
Chief Executive Officer
JOHNSON JOHN
Director
JOHNSON JOHN
Director
TYNDALL JOSEPH A.
Director
TYNDALL JOSEPH A.
Director
THOMAS PAUL
Director
JOHNSON JOHN
Director
JOHNSON JOHN
Director
Hartley Lindsey Marie
CFO
Hartley Lindsey Marie
CFO
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
Burke William P. Mr.
Director
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 02, 2026 | TYNDALL JOSEPH A. Director | Sale | 3,500 | $49.70 | $173,940 | |
| Aug 11, 2026 | Wendell Amy McBride Director | Sale | 13,353 | $48.42 | $646,592 | |
| Aug 10, 2026 | Began Marc A EVP & General Counsel | Sale | 67,500 | $47.35 | $3,195,788 | |
| Aug 07, 2026 | Weiler Kathy Johnson Director | Sale | 14,150 | $45.30 | $640,967 | |
| May 08, 2026 | Wendell Amy McBride Director | Sale | 1,647 | $42.60 | $70,162 | |
| May 07, 2026 | JOHNSON JOHN Director | Sale | 11,050 | $43.26 | $477,968 | |
| May 07, 2026 | Weiler Kathy Johnson Director | Sale | 16,344 | $44.09 | $720,623 | |
| May 07, 2026 | Kemp Jens Chief Marketing Officer | Sale | 4,000 | $43.44 | $173,761 | |
| May 07, 2026 | Hartley Lindsey Marie CFO | Sale | 573 | $43.67 | $25,023 | |
| May 07, 2026 | Hartley Lindsey Marie CFO | Sale | 478 | $43.67 | $20,874 | |
| May 07, 2026 | Quackenbush Doris Sales VP | Sale | 3,878 | $43.51 | $168,720 | |
| Dec 16, 2025 | Wendell Amy McBride Director | Sale | 18,248 | $29.31 | $534,885 | |
| Dec 16, 2025 | Wendell Amy McBride Director | Sale | 20,436 | $29.31 | $599,020 | |
| Dec 16, 2025 | Wendell Amy McBride Director | Sale | 5,000 | $29.31 | $146,560 | |
| Dec 16, 2025 | Weiler Kathy Johnson Director | Sale | 6,580 | $29.55 | $194,439 | |
| Dec 16, 2025 | Weiler Kathy Johnson Director | Sale | 21,825 | $29.55 | $644,863 | |
| Dec 16, 2025 | Weiler Kathy Johnson Director | Sale | 18,248 | $29.55 | $539,174 | |
| Dec 15, 2025 | Hartley Lindsey Marie CFO | Sale | 14,812 | $29.86 | $442,294 | |
| Dec 11, 2025 | Began Marc A EVP & General Counsel | Sale | 13,222 | $30.00 | $396,660 | |
| Dec 10, 2025 | DALE MICHAEL D Chief Executive Officer | Sale | 25,000 | $30.00 | $750,000 | |
| Dec 09, 2025 | JOHNSON JOHN Director | Sale | 13,141 | $29.98 | $393,993 | |
| Dec 09, 2025 | JOHNSON JOHN Director | Sale | 8,545 | $29.98 | $256,196 | |
| Dec 09, 2025 | TYNDALL JOSEPH A. Director | Sale | 10,860 | $30.98 | $336,410 | |
| Dec 09, 2025 | TYNDALL JOSEPH A. Director | Sale | 14,248 | $30.98 | $441,360 | |
| Dec 09, 2025 | THOMAS PAUL Director | Sale | 21,399 | $29.61 | $633,710 | |
| Dec 08, 2025 | JOHNSON JOHN Director | Sale | 11,891 | $31.22 | $371,273 | |
| Dec 08, 2025 | JOHNSON JOHN Director | Sale | 11,802 | $31.26 | $368,931 | |
| Dec 08, 2025 | Hartley Lindsey Marie CFO | Sale | 2,854 | $31.56 | $90,069 | |
| Dec 08, 2025 | Hartley Lindsey Marie CFO | Sale | 11,533 | $31.56 | $363,935 | |
| Nov 11, 2025 | Burke William P. Mr. Director | Sale | 3,591 | $24.02 | $86,249 | |
| Nov 10, 2025 | Burke William P. Mr. Director | Sale | 19,227 | $24.01 | $461,640 | |
| Nov 06, 2025 | Burke William P. Mr. Director | Sale | 5,347 | $24.01 | $128,371 | |
| Nov 05, 2025 | Burke William P. Mr. Director | Sale | 11,431 | $24.05 | $274,893 | |
| Oct 30, 2025 | Burke William P. Mr. Director | Sale | 18,248 | $23.00 | $419,704 | |
| Oct 29, 2025 | Burke William P. Mr. Director | Sale | 19,799 | $22.00 | $435,578 | |
| Oct 29, 2025 | Burke William P. Mr. Director | Sale | 20,436 | $19.15 | $391,435 | |
| Oct 22, 2025 | Burke William P. Mr. Director | Sale | 1,457 | $18.02 | $26,252 | |
| Oct 06, 2025 | Burke William P. Mr. Director | Sale | 736 | $18.00 | $13,249 | |
| Oct 03, 2025 | Burke William P. Mr. Director | Sale | 14,571 | $18.21 | $265,283 | |
| Oct 03, 2025 | Burke William P. Mr. Director | Sale | 7,600 | $18.21 | $138,367 | |
| Oct 02, 2025 | Burke William P. Mr. Director | Sale | 7,620 | $18.01 | $137,200 | |
| Oct 02, 2025 | Burke William P. Mr. Director | Sale | 2,400 | $18.01 | $43,224 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.